EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access

Mobile Dermatoscope Type in Patient-Performed Teledermoscopy

Deonna M Ackermann, Ellie Medcalf, Robin M Turner, Jolyn K Hersch, Monika Janda, Pascale Guitera, H Peter Soyer, Karen Bracken, Linda K Martin, Victoria Mar, Katy J L Bell

JAMA Dermatology · 2026

DOI: 10.1001/jamadermatol.2025.4792 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Dermatology, 2026. Verfasst von Deonna M Ackermann und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Dermoscopy, Skin Neoplasms, Melanoma. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Patient-performed teledermoscopy may improve access to dermatologic care, but evidence to guide dermatoscope selection for patient use is limited.

Objective

To compare a lower-cost, ambient-light, nonpolarized dermatoscope with a higher-cost, illuminated, polarized dermatoscope for patient-performed teledermoscopy following treatment for early-stage melanoma. Design, Setting, and Participants This randomized study within a trial was embedded within the MEL-SELF trial and recruited adults previously treated for early-stage melanoma (American Joint Committee on Cancer stages 0-II) in the patient-led surveillance arm of MEL-SELF from specialist and general practitioner-led skin cancer clinics in Australia from December 2021 to June 2024 with 12-month follow-up. Data were analyzed from February 6, 2025, to August 15, 2025.

Interventions

Participants were randomized (1:1) to receive a polarized (128 [51.0%]) or ambient-light (123 [49.0%]) dermatoscope smartphone attachment. Optional online training was provided. Participants submitted clinician-identified and self-detected lesion images via a secure teledermatology platform at 3-month intervals. Main Outcomes and Measures The primary outcome was the proportion of participants submitting baseline images of sufficient quality for a teledermatologist to provide a management recommendation. Secondary outcomes included the proportion receiving a management recommendation for at least 1 image during the study period, per-image recommendation proportions, device costs, and qualitative assessments of image quality and usability.

Results

Of 251 participants (mean [SD] age, 56.0 [11.6] years; 147 female individuals [59%]), 175 (69.7%) received a teledermatologist management recommendation for baseline images (polarized: 92 [71.9%]; ambient light: 83 [67.5%]; difference, 4.4%; 95% CI, –7.0% to 15.8%). By 12 months, the proportion receiving at least 1 recommendation was similar between groups (polarized: 104 of 128 [81.3%]; ambient light: 94 of 123 [76.4%]; difference, 4.3%; 95% CI, –8.1% to 16.6%). However, a per-image analysis showed more polarized images (913 of 961 [95.0%]) than ambient-light images (706 of 775 [91.1%]) were reportable and supported a recommendation (difference, 3.9%; 95% CI, 1.5% to 6.3%; self-directed lesions: 6.8%; 95% CI, 3.3% to 10.2%). Teledermatologists provided more positive feedback for polarized images; blurriness (n = 14 vs 9) and poor lighting (n = 6 vs 0) were more frequent with ambient-light images. Patient usability ratings were similar (moderately/very easy: 39.8% vs 36.6%; difference, 3.2%; 95% CI, –8.8% to 15.3%), but ambient-light dermatoscope users reported more image quality issues. The polarized device was more expensive ($324.16 vs $35.40). Conclusions and Relevance The results of this study within a trial indicate that both devices enabled patients to perform dermoscopy and receive teledermatology recommendations. The modest image quality advantages of the polarized device must be weighed against its substantially higher cost. Trial Registration anzctr.org.au Identifier: ACTRN12621000176864

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermoscopySkin NeoplasmsMelanomaHumansFemaleMaleMiddle AgedTelemedicineAdultSmartphoneAgedAustraliaFollow-Up StudiesEquipment Design

Autor:innen und Institutionen

  • School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
  • Biostatistics Centre, University of Otago, Dunedin, New Zealand.
  • Centre for Health Services Research, University of Queensland, Brisbane, Queensland, Australia.
  • Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.

Zitieren

APA

Ackermann, D. M., Medcalf, E., Turner, R. M., Hersch, J. K., Janda, M., Guitera, P., Soyer, H. P., Bracken, K., Martin, L. K., Mar, V., & Bell, K. J. L. (2026). Mobile Dermatoscope Type in Patient-Performed Teledermoscopy. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2025.4792

Vancouver

Ackermann DM, Medcalf E, Turner RM, Hersch JK, Janda M, Guitera P, et al. Mobile Dermatoscope Type in Patient-Performed Teledermoscopy. JAMA Dermatology. 2026. doi:10.1001/jamadermatol.2025.4792

BibTeX
@article{Ackermann2026,
  author = {Ackermann, Deonna M and Medcalf, Ellie and Turner, Robin M and Hersch, Jolyn K and Janda, Monika and Guitera, Pascale and Soyer, H Peter and Bracken, Karen and Martin, Linda K and Mar, Victoria and Bell, Katy J L},
  title = {Mobile Dermatoscope Type in Patient-Performed Teledermoscopy},
  journal = {JAMA Dermatology},
  year = {2026},
  doi = {10.1001/jamadermatol.2025.4792}
}
Kostenlos starten →